Gabriella Sammarelli

Parma, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Long-term prognostic impact of chromosome 1 abnormalities in newly diagnosed multiple myeloma patients: a monocentric study.

Long-term prognostic impact of chromosome 1 abnormalities in newly diagnosed multiple myeloma patients: a monocentric study.

Journal: Annals of hematology

Published: March 11, 2026

PYGO2 is overexpressed in multiple myeloma patients with 1q21 amplification, driving plasma cell proliferation and cell cycle progression.

PYGO2 is overexpressed in multiple myeloma patients with 1q21 amplification, driving plasma cell proliferation and cell cycle progression.

Journal: Cancer gene therapy

Published: November 27, 2025

Inhibition of the Atypical Kinase WNK1 as a Therapeutic Strategy in TAL-related T-cell Acute Lymphoblastic Leukemia.

Inhibition of the Atypical Kinase WNK1 as a Therapeutic Strategy in TAL-related T-cell Acute Lymphoblastic Leukemia.

Journal: Blood

Published: June 27, 2025

Identification of clinical-biological features of newly diagnosed early relapse multiple myeloma patients eligible for autologous stem cell transplantation.

Identification of clinical-biological features of newly diagnosed early relapse multiple myeloma patients eligible for autologous stem cell transplantation.

Journal: EJHaem

Published: January 06, 2024

CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders.

CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders.

Journal: International journal of molecular sciences

Published: November 19, 2023

CD38 expression by plasma cells in extramedullary multiple myeloma.

CD38 expression by plasma cells in extramedullary multiple myeloma.

Journal: Haematologica

Published: August 28, 2023

Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma.

Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma.

Journal: Haematologica

Published: March 24, 2023

Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML.

Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML.

Journal: Nature communications

Published: February 03, 2023

The impact of CD56 expression in smoldering myeloma patients on early progression.

The impact of CD56 expression in smoldering myeloma patients on early progression.

Journal: Hematological oncology

Published: November 28, 2022

Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response.

Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response.

Journal: Oncoimmunology

Published: September 15, 2022

Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma.

Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma.

Journal: Nature communications

Published: July 29, 2022

Role of 1q21 in Multiple Myeloma: From Pathogenesis to Possible Therapeutic Targets.

Role of 1q21 in Multiple Myeloma: From Pathogenesis to Possible Therapeutic Targets.

Journal: Cells

Published: May 11, 2021

Showing 1-12 of 27

Last Updated: 09/26/2026